Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

This study has been completed.
Sponsor:
Information provided by:
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00096746
First received: November 15, 2004
Last updated: April 12, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)